BRODALUMAB (Kyntheum®)

Clinical Indication

Moderate to severe plaque psoriasis

Comments

In line with NICE TA 511

 

Local guidance

Implementation date 21st June 2018

Date of classification

May 2018

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.